Archives
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe Allergy
Authors call for aggressively delabeling these patients to avoid treatment failure
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine
ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep
Significantly higher chance of experiencing delirium seen for those with worsening of their PSQI over three scores
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo
ASA: Fibrinogen-to-Albumin Ratio Is Risk Factor for Preeclampsia
FAR was one of only two markers that were significant in predicting both PE and PE with severe features
ASA: Repeated Fasting Increases Malnutrition Risk in Patients Undergoing Multiple Surgeries
Higher odds of hospital death, higher adjusted total cost, and longer hospital stays seen for patients with malnutrition
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
Findings show higher risk for nonclearing vitreous hemorrhage, retinal tear and detachment, anterior vitrectomy, and glaucoma surgery
AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir
